Ashfield Capital Partners, LLC Abbott Laboratories Transaction History
Ashfield Capital Partners, LLC
- $1.19 Billion
- Q3 2022
A detailed history of Ashfield Capital Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Ashfield Capital Partners, LLC holds 57,706 shares of ABT stock, worth $6.54 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
57,706
Previous 57,504
0.35%
Holding current value
$6.54 Million
Previous $6.25 Million
10.63%
% of portfolio
0.47%
Previous 0.49%
Shares
22 transactions
Others Institutions Holding ABT
# of Institutions
3,161Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.19M-
Vanguard Group Inc Valley Forge, PA166MShares$18.9 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$14.9 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.44 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.14 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.49 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $199B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...